Blood cancers, Cell type, High grade lymphoma, Lymphoma, Myeloma, Non-Hodgkin lymphoma (NHL)
Open
Phase 1/2
This trial is looking at a new drug called DTP3 for diffuse large B cell lymphoma or myeloma.
It is for people whose treatment has stopped working or their cancer has got worse.
Recruitment start: 1 July 2022
Recruitment end: 31 March 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Aris Chaidos
Imperial College London
Institute of Cancer Research (ICR)
Medical Research Council (MRC)
Last reviewed: 14 Mar 2025
CRUK internal database number: 18444
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
